FDA Reportedly Shelves Fast-Track Drug Review Pilot Program During Leadership Vacuum: Report
The United States Food and Drug Administration has suspended its expedited drug review pilot initiative. This decision comes during a period of ongoing internal leadership uncertainty at the agency.
Read More